首页 > 最新文献

Digestive Surgery最新文献

英文 中文
Response Rate Correlates with the Conversion Rate in Patients with Advanced Hepatocellular Carcinoma Treated with Systemic or Hepatic Artery Infusion Chemotherapy: A Systematic Review. 晚期肝癌患者接受全身或肝动脉输注化疗的应答率与转换率相关:一项系统综述
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-23 DOI: 10.1159/000550237
Masayuki Okuno, Hiroto Nishino, Keisuke Okura, Takamichi Ishii, Hiroki Hashida, Etsuro Hatano

Introduction: The appropriate regimen for induction therapy with the intent of conversion therapy for advanced hepatocellular carcinoma (HCC) is unknown. This study aimed to evaluate whether the overall response rate (ORR) of chemotherapy correlates with the conversion rate.

Methods: The studies of phase 2/3 trials of systemic or hepatic artery infusion chemotherapy (HAIC) for patients with advanced HCC were searched. Spearman's correlation coefficient was calculated to measure the strength of the relationship between the conversion rate and the ORR.

Results: A total of 42 patient groups from 32 trials were included in the analysis. The ORR and conversion rates in a total of 3,516 patients were 24.7% and 8.3%, respectively. The analysis of only the patient groups treated with 1st-line immune checkpoint inhibitors, tyrosine kinase inhibitors or HAIC revealed a strong correlation between the ORR and the conversion rate (ρ = 0.647, p = 0.0003). In addition, strong correlations between the ORR and median progression-free survival (PFS)/overall survival (OS) were observed (ρ = 0.772, p < 0.0001 and ρ = 0.754, p < 0.0001, respectively).

Conclusion: Because of the strong correlations of the ORR with the conversion rate and PFS/OS, regimens with high ORRs may be used for patients with advanced HCC who are potential candidates for conversion therapy.

.

背景:对于晚期肝细胞癌(HCC),诱导治疗和转化治疗的合适方案尚不清楚。本研究旨在评估化疗的总有效率(overall response rate, ORR)是否与转换率相关。摘要:检索了晚期HCC患者全身或肝动脉输注化疗(HAIC)的2/3期试验研究。来自32项试验的42组患者被纳入分析。3516例患者的ORR和转换率分别为24.7%和8.3%。仅对接受一线免疫检查点抑制剂、酪氨酸激酶抑制剂或HAIC治疗的患者组进行分析,结果显示ORR与转化率之间存在很强的相关性(ρ=0.647, p=0.0003)。此外,观察到ORR与中位PFS/OS之间存在强相关性(ρ=0.772, p
{"title":"Response Rate Correlates with the Conversion Rate in Patients with Advanced Hepatocellular Carcinoma Treated with Systemic or Hepatic Artery Infusion Chemotherapy: A Systematic Review.","authors":"Masayuki Okuno, Hiroto Nishino, Keisuke Okura, Takamichi Ishii, Hiroki Hashida, Etsuro Hatano","doi":"10.1159/000550237","DOIUrl":"10.1159/000550237","url":null,"abstract":"<p><p><p>Introduction: The appropriate regimen for induction therapy with the intent of conversion therapy for advanced hepatocellular carcinoma (HCC) is unknown. This study aimed to evaluate whether the overall response rate (ORR) of chemotherapy correlates with the conversion rate.</p><p><strong>Methods: </strong>The studies of phase 2/3 trials of systemic or hepatic artery infusion chemotherapy (HAIC) for patients with advanced HCC were searched. Spearman's correlation coefficient was calculated to measure the strength of the relationship between the conversion rate and the ORR.</p><p><strong>Results: </strong>A total of 42 patient groups from 32 trials were included in the analysis. The ORR and conversion rates in a total of 3,516 patients were 24.7% and 8.3%, respectively. The analysis of only the patient groups treated with 1st-line immune checkpoint inhibitors, tyrosine kinase inhibitors or HAIC revealed a strong correlation between the ORR and the conversion rate (ρ = 0.647, p = 0.0003). In addition, strong correlations between the ORR and median progression-free survival (PFS)/overall survival (OS) were observed (ρ = 0.772, p < 0.0001 and ρ = 0.754, p < 0.0001, respectively).</p><p><strong>Conclusion: </strong>Because of the strong correlations of the ORR with the conversion rate and PFS/OS, regimens with high ORRs may be used for patients with advanced HCC who are potential candidates for conversion therapy. </p>.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"23-34"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12854685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145817970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotically Assisted Gastric Resections Using the hinotori™: A Cadaveric Feasibility Study. 机器人辅助胃切除使用hinotori™:尸体可行性研究。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-28 DOI: 10.1159/000548938
Christoph Wandhöfer, Franco Roviello, Vladimir J Lozanovski, Evangelos Tagkalos, Peter P Grimminger, Hauke Lang, Suzanne S Gisbertz

Introduction: In this first preclinical evaluation study of the hinotori™ system in gastric resection procedure, its capabilities to perform distal and total gastrectomy while using human cadaver models were evaluated.

Methods: Three robotic distal gastrectomies (RADGs) and one total gastrectomy were performed in human cadavers using the same setup. A delta-shaped anastomosis in the RADG procedures were performed with a manual stapler.

Results: The mean operative time for three distal gastrectomies was 118 min, while the total gastrectomy procedure focused on the resection only. The dissection could be made up to pulmonary veins, while the entire setup was kept. The procedures were done safely according to the surgical standards with smooth instrument and overall performance without any complications seen. An ergonomic surgeon cockpit and head rest supported the outcome.

Conclusion: Docking-free design and human arm-like movement with a high degree of operation arm mobility showed a wide range of motion of the wristed robotic instruments. This could be beneficial for multiquadrant procedures resulting in potential shorter procedures times with smother performance, which should be evaluated in further studies.

.

在这项首次对hinotori™系统在胃切除手术中的临床前评估研究中,我们对其在使用人体尸体模型时进行远端和全胃切除的能力进行了评估。方法:采用相同的装置对人尸体进行了3次机器人远端胃切除术(RADG)和1次全胃切除术(RATG)。RADG手术采用手工吻合器进行三角形吻合。结果:3例远端胃切除术的平均手术时间为118分钟,而全胃切除术仅集中于切除。在保留整个结构的同时,可将解剖部分补至肺静脉。手术按照手术标准安全完成,器械光滑,整体表现良好,无并发症发生。人体工程学外科医生座舱和头枕支持结果。结论:腕式机器人器械的无对接设计和类似人臂的运动方式,具有高度的操作臂机动性,具有较大的运动范围。这对于多象限手术可能是有益的,可以缩短手术时间,并且效果更好,这应该在进一步的研究中进行评估。
{"title":"Robotically Assisted Gastric Resections Using the hinotori™: A Cadaveric Feasibility Study.","authors":"Christoph Wandhöfer, Franco Roviello, Vladimir J Lozanovski, Evangelos Tagkalos, Peter P Grimminger, Hauke Lang, Suzanne S Gisbertz","doi":"10.1159/000548938","DOIUrl":"10.1159/000548938","url":null,"abstract":"<p><p><p>Introduction: In this first preclinical evaluation study of the hinotori™ system in gastric resection procedure, its capabilities to perform distal and total gastrectomy while using human cadaver models were evaluated.</p><p><strong>Methods: </strong>Three robotic distal gastrectomies (RADGs) and one total gastrectomy were performed in human cadavers using the same setup. A delta-shaped anastomosis in the RADG procedures were performed with a manual stapler.</p><p><strong>Results: </strong>The mean operative time for three distal gastrectomies was 118 min, while the total gastrectomy procedure focused on the resection only. The dissection could be made up to pulmonary veins, while the entire setup was kept. The procedures were done safely according to the surgical standards with smooth instrument and overall performance without any complications seen. An ergonomic surgeon cockpit and head rest supported the outcome.</p><p><strong>Conclusion: </strong>Docking-free design and human arm-like movement with a high degree of operation arm mobility showed a wide range of motion of the wristed robotic instruments. This could be beneficial for multiquadrant procedures resulting in potential shorter procedures times with smother performance, which should be evaluated in further studies. </p>.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"10-15"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12716846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145631167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Limb Roux-en-Y Reconstruction for Glycemic Control in Patients with Gastric Cancer and Type 2 Diabetes: One-Year Outcomes of Oncometabolic Surgery. 长肢Roux-en-Y重建用于胃癌和2型糖尿病患者的血糖控制:肿瘤代谢手术的1年结果
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-10-27 DOI: 10.1159/000549195
Yeongkeun Kwon, Hayun Kim, Dohyang Kim, Chang Min Lee, Jong-Han Kim, Sungsoo Park

Background: Long-limb Roux-en-Y (LLRY) reconstruction has recently been implemented as an oncometabolic surgery to improve glycemic control following surgery for gastric cancer (GC); however, data on its feasibility are insufficient. We investigated the 1-year outcomes of LLRY reconstruction for glycemic control in patients with type 2 diabetes (T2D).

Methods: We reviewed the records of 15 patients with GC and T2D who underwent LLRY reconstruction after gastrectomy, with biliopancreatic and Roux limb lengths of 130-250 cm, to improve postoperative glycemic control. The primary outcome was the T2D remission (glycated hemoglobin <6.5% without antidiabetic medication) rate at 12 months postoperatively. The diabetes prediction (DP) score and Korean nationwide average T2D remission rates following GC surgery were compared.

Results: The mean patient age was 66.5 years (standard deviation [SD] 9.6), mean body mass index was 26.4 kg/m2 (SD 4.4), and mean glycated hemoglobin level was 7.7% (SD 1.5). The overall T2D remission rate was 46.7%. The postoperative T2D remission rate was 12.9% higher than the DP score estimate (33.8%) and 25.7% higher than the Korean national average rate (21%) of T2D remission following GC surgery.

Conclusion: Our results show that LLRY reconstruction after gastrectomy is an effective oncometabolic surgery for treating T2D and GC.

.

背景:长肢Roux-en-Y (LLRY)重建最近被作为一种肿瘤代谢手术实施,以改善胃癌(GC)手术后的血糖控制;然而,关于其可行性的数据不足。我们研究了t2dm患者1年的LLRY重建血糖控制结果。方法:回顾15例胃切除术后行肝胆胰和Roux肢体长度为130 ~ 250 cm的GC和T2D患者的记录,以改善术后血糖控制。结果:患者平均年龄为66.5岁(标准差[SD] 9.6),平均体重指数为26.4 kg/m2 (SD 4.4),平均糖化血红蛋白水平为7.7% (SD 1.5)。总体T2D缓解率为46.7%。术后T2D缓解率比DP评分估计(33.8%)高12.9%,比韩国GC手术后T2D平均缓解率(21%)高25.7%。结论:胃切除术后LLRY重建是治疗T2D和GC的有效肿瘤代谢手术。
{"title":"Long-Limb Roux-en-Y Reconstruction for Glycemic Control in Patients with Gastric Cancer and Type 2 Diabetes: One-Year Outcomes of Oncometabolic Surgery.","authors":"Yeongkeun Kwon, Hayun Kim, Dohyang Kim, Chang Min Lee, Jong-Han Kim, Sungsoo Park","doi":"10.1159/000549195","DOIUrl":"10.1159/000549195","url":null,"abstract":"<p><p><p>Background: Long-limb Roux-en-Y (LLRY) reconstruction has recently been implemented as an oncometabolic surgery to improve glycemic control following surgery for gastric cancer (GC); however, data on its feasibility are insufficient. We investigated the 1-year outcomes of LLRY reconstruction for glycemic control in patients with type 2 diabetes (T2D).</p><p><strong>Methods: </strong>We reviewed the records of 15 patients with GC and T2D who underwent LLRY reconstruction after gastrectomy, with biliopancreatic and Roux limb lengths of 130-250 cm, to improve postoperative glycemic control. The primary outcome was the T2D remission (glycated hemoglobin <6.5% without antidiabetic medication) rate at 12 months postoperatively. The diabetes prediction (DP) score and Korean nationwide average T2D remission rates following GC surgery were compared.</p><p><strong>Results: </strong>The mean patient age was 66.5 years (standard deviation [SD] 9.6), mean body mass index was 26.4 kg/m2 (SD 4.4), and mean glycated hemoglobin level was 7.7% (SD 1.5). The overall T2D remission rate was 46.7%. The postoperative T2D remission rate was 12.9% higher than the DP score estimate (33.8%) and 25.7% higher than the Korean national average rate (21%) of T2D remission following GC surgery.</p><p><strong>Conclusion: </strong>Our results show that LLRY reconstruction after gastrectomy is an effective oncometabolic surgery for treating T2D and GC. </p>.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"1-9"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145376355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgement to Reviewers. 向审稿人致谢。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-11-10 DOI: 10.1159/000549027
{"title":"Acknowledgement to Reviewers.","authors":"","doi":"10.1159/000549027","DOIUrl":"https://doi.org/10.1159/000549027","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"1"},"PeriodicalIF":1.2,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145488062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Early Oral Feeding on Postoperative Outcomes after Elective Colorectal Surgery: A Systematic Review and Meta-Analysis. 早期口服喂养对择期结直肠手术术后效果的影响:系统综述和荟萃分析。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-18 DOI: 10.1159/000542595
Soo Young Lee, Eon Chul Han

Introduction: This study aimed to evaluate the influence of early oral feeding (EOF), a key component of enhanced recovery after surgery protocols, on postoperative outcomes in patients undergoing elective colorectal surgery.

Methods: We searched the MEDLINE, Embase, Cochrane Library, and KoreaMed databases to include randomized clinical trials comparing EOF that started on postoperative day 1 and conventional oral feeding that commenced after first flatus. Two authors independently screened the retrieved records and extracted data. The primary outcome was total complications. Data were pooled, and the overall effect size was calculated using a fixed-effect model.

Results: We screened 13 studies, and 1,556 patients were included in the analysis. The EOF group exhibited fewer total complications (odds ratio [OR] 0.50; 95% confidence interval [CI] 0.38-0.65). Anastomotic leakage was also reduced in the EOF group (OR: 0.40; 95% CI: 0.19-0.83); however, an increased incidence of vomiting (OR: 1.58; 95% CI: 1.11-2.26) as well as a tendency of higher rate of nasogastric tube reinsertion (OR: 1.49; 95% CI: 0.96-2.31) were observed. The EOF group demonstrated a decreased time to flatus (mean difference [MD] -0.87; 95% CI: -1.00 to -0.74) and shortened hospital stay (MD: -0.76; 95% CI: -0.89 to -0.6). No significant difference in mortality was observed between the two groups (OR: 0.54; 95% CI: 0.15-2.01).

Conclusion: EOF proved to be a safe and effective practice for patients undergoing elective colorectal surgery. However, the increased incidence of vomiting necessitates careful consideration.

简介:本研究旨在评估早期口服喂养(EOF)对择期结直肠手术患者术后效果的影响:本研究旨在评估早期口服喂食(EOF)对择期结直肠手术患者术后效果的影响:我们检索了 Medline、Embase、Cochrane Library 和 KoreaMed 数据库,将术后第 1 天开始的早期口服喂养与首次排气后开始的传统口服喂养进行比较的随机临床试验纳入其中。两位作者独立筛选了检索到的记录并提取了数据。主要结果是总并发症。汇总数据并计算总体效应大小:我们筛选了 13 项研究,共有 1556 名患者纳入分析。EOF 组的总并发症较少(几率比 [OR] 0.50;95% 置信区间 [CI] 0.38 至 0.65)。EOF 组的吻合口漏也有所减少(OR 0.40;95% CI 0.19 至 0.83);但呕吐发生率增加(OR 1.58;95% CI 1.11 至 2.26),鼻胃管重新插入率也有上升趋势(OR 1.49;95% CI 0.96 至 2.31)。EOF 组缩短了排气时间(平均差 [MD] -0.87;95% CI -1.00 至 -0.74),缩短了住院时间(平均差 -0.76;95% CI -0.89 至 -0.6)。两组患者的死亡率无明显差异(OR 0.54;95% CI 0.15 至 2.01):对于接受择期结直肠手术的患者来说,EOF 被证明是一种安全有效的方法。结论:对于接受择期结直肠手术的患者来说,EOF 被证明是一种安全有效的做法,但需要慎重考虑呕吐发生率的增加。
{"title":"Impact of Early Oral Feeding on Postoperative Outcomes after Elective Colorectal Surgery: A Systematic Review and Meta-Analysis.","authors":"Soo Young Lee, Eon Chul Han","doi":"10.1159/000542595","DOIUrl":"10.1159/000542595","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to evaluate the influence of early oral feeding (EOF), a key component of enhanced recovery after surgery protocols, on postoperative outcomes in patients undergoing elective colorectal surgery.</p><p><strong>Methods: </strong>We searched the MEDLINE, Embase, Cochrane Library, and KoreaMed databases to include randomized clinical trials comparing EOF that started on postoperative day 1 and conventional oral feeding that commenced after first flatus. Two authors independently screened the retrieved records and extracted data. The primary outcome was total complications. Data were pooled, and the overall effect size was calculated using a fixed-effect model.</p><p><strong>Results: </strong>We screened 13 studies, and 1,556 patients were included in the analysis. The EOF group exhibited fewer total complications (odds ratio [OR] 0.50; 95% confidence interval [CI] 0.38-0.65). Anastomotic leakage was also reduced in the EOF group (OR: 0.40; 95% CI: 0.19-0.83); however, an increased incidence of vomiting (OR: 1.58; 95% CI: 1.11-2.26) as well as a tendency of higher rate of nasogastric tube reinsertion (OR: 1.49; 95% CI: 0.96-2.31) were observed. The EOF group demonstrated a decreased time to flatus (mean difference [MD] -0.87; 95% CI: -1.00 to -0.74) and shortened hospital stay (MD: -0.76; 95% CI: -0.89 to -0.6). No significant difference in mortality was observed between the two groups (OR: 0.54; 95% CI: 0.15-2.01).</p><p><strong>Conclusion: </strong>EOF proved to be a safe and effective practice for patients undergoing elective colorectal surgery. However, the increased incidence of vomiting necessitates careful consideration.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"26-35"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor regarding the Article: "Pathologic Outcomes and Survival in Patients with Rectal Cancer and Increased Body Mass Index". 致编辑关于文章“直肠癌患者的病理结局和生存与体重指数增加”的信。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-01 DOI: 10.1159/000545530
Xiaobo Xie
{"title":"Letter to the Editor regarding the Article: \"Pathologic Outcomes and Survival in Patients with Rectal Cancer and Increased Body Mass Index\".","authors":"Xiaobo Xie","doi":"10.1159/000545530","DOIUrl":"10.1159/000545530","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"152-153"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the Risk of Developing a Crohn's Disease Increased after Appendectomy? A Systematic Review of the Literature and Meta-Analysis. 阑尾切除术后患克罗恩病的风险增加了吗?对文献和荟萃分析进行系统回顾。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-04-22 DOI: 10.1159/000545339
Isabelle Uhe, Eleftherios Gialamas, Christophe Combescure, Christian Toso, Emilie Liot, Guillaume Meurette, Frederic Ris, Jeremy Meyer

Introduction: The effect of appendectomy on the development of Crohn's disease (CD) is a matter of debate. The aim of this systematic review and meta-analysis was to gather the latest published data to determine whether patients with a history of appendectomy have an increased risk of developing CD or not.

Methods: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched for case-control and cohort studies assessing the risk of developing CD after appendectomy. The pooled adjusted and not adjusted odds ratio (OR) with 95% confidence intervals (CIs) were calculated for case-control studies. Heterogeneity was assessed. Studies were ranked using the Newcastle-Ottawa Scale (NOS) and were all of good quality.

Results: Fourteen case-control studies and 6 cohort studies were included. Meta-analysis of case-control studies (33,243 patients) of raw OR shows a positive association between appendectomy and CD (OR: 1.51, 95% CI: 0.97-2.36, I2 = 87%), which was not statistically significant (p = 0.069). The meta-analysis of adjusted OR shows that appendectomy represents a statistically significant risk factor for the development of CD (OR: 1.86, 95% CI: 1.01-3.45, p = 0.047, I2 = 89%).

Conclusion: Appendectomy appears to be a risk factor for the development of CD. However, the discrepant results obtained by meta-analysis of unadjusted OR, the heterogeneity between studies, and the lack of precision of the magnitude of the association mandate confirmation by a large epidemiological study.

阑尾切除术对克罗恩病(CD)发展的影响是一个有争议的问题。本系统综述和荟萃分析的目的是收集最新发表的数据,以确定有阑尾切除术史的患者是否会增加患乳糜泻的风险。方法检索MEDLINE、Embase和Cochrane中央对照试验注册库,检索评估阑尾切除术后发生CD风险的病例对照和队列研究。对病例对照研究计算合并调整和未调整的优势比(OR)和95%可信区间(CI)。评估异质性。研究使用纽卡斯尔-渥太华量表(NOS)进行排名,所有研究的质量都很好。结果纳入14项病例对照研究和6项队列研究。病例对照研究(33’243例)的meta分析显示,阑尾切除术与CD呈正相关(OR: 1.51, 95% CI: 0.97 ~ 2.36, I2=87%),但差异无统计学意义(p=0.069)。校正优势比的荟萃分析显示,阑尾切除术是CD发生的具有统计学意义的危险因素(OR: 1.86, 95% CI: 1.01 ~ 3.45, p=0.047)。I2 = 89%)。结论:阑尾切除术似乎是发生CD的一个危险因素。然而,未调整OR的meta分析结果存在差异,研究之间存在异质性,且大型流行病学研究缺乏相关性程度的准确性。
{"title":"Is the Risk of Developing a Crohn's Disease Increased after Appendectomy? A Systematic Review of the Literature and Meta-Analysis.","authors":"Isabelle Uhe, Eleftherios Gialamas, Christophe Combescure, Christian Toso, Emilie Liot, Guillaume Meurette, Frederic Ris, Jeremy Meyer","doi":"10.1159/000545339","DOIUrl":"10.1159/000545339","url":null,"abstract":"<p><strong>Introduction: </strong>The effect of appendectomy on the development of Crohn's disease (CD) is a matter of debate. The aim of this systematic review and meta-analysis was to gather the latest published data to determine whether patients with a history of appendectomy have an increased risk of developing CD or not.</p><p><strong>Methods: </strong>MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched for case-control and cohort studies assessing the risk of developing CD after appendectomy. The pooled adjusted and not adjusted odds ratio (OR) with 95% confidence intervals (CIs) were calculated for case-control studies. Heterogeneity was assessed. Studies were ranked using the Newcastle-Ottawa Scale (NOS) and were all of good quality.</p><p><strong>Results: </strong>Fourteen case-control studies and 6 cohort studies were included. Meta-analysis of case-control studies (33,243 patients) of raw OR shows a positive association between appendectomy and CD (OR: 1.51, 95% CI: 0.97-2.36, I2 = 87%), which was not statistically significant (p = 0.069). The meta-analysis of adjusted OR shows that appendectomy represents a statistically significant risk factor for the development of CD (OR: 1.86, 95% CI: 1.01-3.45, p = 0.047, I2 = 89%).</p><p><strong>Conclusion: </strong>Appendectomy appears to be a risk factor for the development of CD. However, the discrepant results obtained by meta-analysis of unadjusted OR, the heterogeneity between studies, and the lack of precision of the magnitude of the association mandate confirmation by a large epidemiological study.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"192-203"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143973448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of Telementoring during Robot-Assisted Minimally Invasive Esophagectomy. 在机器人辅助微创食管切除术中使用 Telementoring 的可行性。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-23 DOI: 10.1159/000542035
Robin B den Boer, Cas de Jongh, Gijs I van Boxel, Philippe Rouanet, Anne Mourregot, Jelle P Ruurda, Richard van Hillegersberg

Introduction: Telementoring could increase the quality, reduce the time, and increase cost efficiency of the proctoring program for robot-assisted minimally invasive esophagectomy (RAMIE). However, feasibility is unclear as no studies assessed telementoring for RAMIE.

Methods: The feasibility of telementoring was assessed during the thoracic part of RAMIE procedures in three high-volume centers. RAMIEs were performed by trained surgeons, proctored by two experts. The primary outcome was the impact of the technology on conveying and understanding instructions.

Results: Between December 2021 and December 2022, nine RAMIE procedures were proctored using telementoring. Overall quality of the telementoring technique was scored good to excellent (median score: good). The vast majority of the 24 proctor instructions were conveyed and understood fluently (n = 21, 96%). Most proctor instructions were aimed at improving surgical exposure (n = 9, 38%). The major point of criticism was the use of the audio as the communication through the headset of the performing surgeon was not accessible by the complete team.

Discussion: Telementoring is deemed feasible for proctoring trained RAMIE surgeons after onsite proctoring. Technical improvements with regard to audio technology are warranted for broad implementation, especially in earlier training settings. The role of telementoring in the training pathway of learning surgeons needs clinical validation.

导言:导师制可以提高机器人辅助微创食管切除术(RAMIE)的监考质量、缩短时间并提高成本效益。然而,由于没有研究对 RAMIE 的监考进行评估,因此可行性尚不明确。方法 在三家高产量中心对 RAMIE 手术胸腔部分的导师制可行性进行了评估。RAMIE 由经过培训的外科医生进行,并由两名专家进行监查。主要结果是该技术对传达和理解指令的影响。结果 在2021年12月至2022年12月期间,九例RAMIE手术使用了远程指导技术。辅导技术的总体质量被评为良好至优秀(中位数:良好)。在 24 项监考指导中,绝大多数都能流利地传达和理解(21 项,96%)。大多数监考指导旨在改善手术暴露(9 人,占 38%)。主要的批评点在于音频的使用,因为整个团队无法通过手术医生的耳机进行交流。结论 在现场监考之后,对经过培训的 RAMIE 外科医生进行 Telementoring 监考是可行的。为了广泛实施,尤其是在早期培训环境中,有必要对音频技术进行技术改进。导师制在学习型外科医生培训过程中的作用还需要临床验证。研究注册号:21/322 注册日期:2021 年 5 月 14 日:14-5-2021.
{"title":"Feasibility of Telementoring during Robot-Assisted Minimally Invasive Esophagectomy.","authors":"Robin B den Boer, Cas de Jongh, Gijs I van Boxel, Philippe Rouanet, Anne Mourregot, Jelle P Ruurda, Richard van Hillegersberg","doi":"10.1159/000542035","DOIUrl":"10.1159/000542035","url":null,"abstract":"<p><strong>Introduction: </strong>Telementoring could increase the quality, reduce the time, and increase cost efficiency of the proctoring program for robot-assisted minimally invasive esophagectomy (RAMIE). However, feasibility is unclear as no studies assessed telementoring for RAMIE.</p><p><strong>Methods: </strong>The feasibility of telementoring was assessed during the thoracic part of RAMIE procedures in three high-volume centers. RAMIEs were performed by trained surgeons, proctored by two experts. The primary outcome was the impact of the technology on conveying and understanding instructions.</p><p><strong>Results: </strong>Between December 2021 and December 2022, nine RAMIE procedures were proctored using telementoring. Overall quality of the telementoring technique was scored good to excellent (median score: good). The vast majority of the 24 proctor instructions were conveyed and understood fluently (n = 21, 96%). Most proctor instructions were aimed at improving surgical exposure (n = 9, 38%). The major point of criticism was the use of the audio as the communication through the headset of the performing surgeon was not accessible by the complete team.</p><p><strong>Discussion: </strong>Telementoring is deemed feasible for proctoring trained RAMIE surgeons after onsite proctoring. Technical improvements with regard to audio technology are warranted for broad implementation, especially in earlier training settings. The role of telementoring in the training pathway of learning surgeons needs clinical validation.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"1-8"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Colorectal Liver Metastases Undergoing Liver Resection: The NONCOLMET Study Group. 非结直肠肝转移患者行肝切除术:non - colmet研究组。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-09-23 DOI: 10.1159/000548423
Marcello Di Martino, Giorgio Ercolani, Federica Cipriani, Gianluca Baiocchi, Roberto Bordonaro, Matteo Cescon, Antonio Frena, Felice Giuliante, Gianluca Grazi, Salvatore Gruttadauria, Giovanni Marchegiani, Riccardo Memeo, Fabrizio Panaro, Fabrizio Romano, Andrea Ruzzenente, Marcello Spampinato, Guido Alberto Tiberio, Guido Torzilli, Roberto Troisi, Matteo Donadon

Introduction: While the resection of colorectal liver metastases is a well-established procedure, with survival rates superior to chemotherapy alone, controversial data still exist on liver resection for non-colorectal liver metastases (NCRLM). These patients comprise a diverse and heterogeneous group usually excluded from surgery. To date, only few retrospective reports are available on the surgical treatment of NCRLM. The NONCOLMET study aimed to build a comprehensive registry of patients undergoing liver resection for NCRLM, providing robust retrospective and prospective data to describe clinical practices, outcomes, and identify prognostic factors.

Methods: The study consists of two phases: (1) retrospective collection of data from patients treated between 2010 and 2024 and (2) prospective enrolment from 2025. Patients aged ≥18 years with histologically confirmed NCRLM undergoing liver resection will be included. Data will be recorded via a standardized electronic case report form on the RedCap platform. The following endpoints will be evaluated: oncological outcomes including overall survival, disease-free survival, and disease relapse; post-operative mortality at 30 and 90 days with causes of death; post-procedural complications; predictor variables of short- and long-term outcomes. These outcomes will be used to elaborate a risk score model.

Conclusions: NONCOLMET will offer crucial insights into the surgical management of NCRLM, helping refine patient selection criteria and informing future clinical guidelines.

背景:虽然结肠直肠肝转移瘤(CRLM)切除术是一种成熟的手术,其生存率优于单纯化疗,但非结肠直肠肝转移瘤(NCRLM)的肝切除术仍存在争议。这些患者包括一个多样化和异质的群体,通常被排除在手术之外。到目前为止,关于NCRLM手术治疗的回顾性报道很少。NONCOLMET研究旨在建立一个全面的NCRLM肝切除术患者注册表,提供可靠的回顾性和前瞻性数据来描述临床实践、结果和确定预后因素。方法:该研究包括两个阶段:(1)回顾性收集2010-2024年期间接受治疗的患者数据;(2)从2025年开始前瞻性招募。年龄≥18岁,经组织学证实行肝切除术的NCRLM患者将被纳入研究。数据将通过RedCap平台上的标准化电子病例报告表格(eCRF)进行记录。将评估以下终点:肿瘤预后,包括总生存期(OS)、无病生存期(DFS)和疾病复发;术后30天和90天的死亡率,包括死因;术后并发症;短期和长期结果的预测变量。这些结果将用于制定风险评分模型。该研究方案已在clinaltrials .gov注册(NCT06542926)。结论:NONCOLMET将为NCRLM的手术治疗提供重要的见解,帮助完善患者选择标准,并为未来的临床指南提供信息。
{"title":"Non-Colorectal Liver Metastases Undergoing Liver Resection: The NONCOLMET Study Group.","authors":"Marcello Di Martino, Giorgio Ercolani, Federica Cipriani, Gianluca Baiocchi, Roberto Bordonaro, Matteo Cescon, Antonio Frena, Felice Giuliante, Gianluca Grazi, Salvatore Gruttadauria, Giovanni Marchegiani, Riccardo Memeo, Fabrizio Panaro, Fabrizio Romano, Andrea Ruzzenente, Marcello Spampinato, Guido Alberto Tiberio, Guido Torzilli, Roberto Troisi, Matteo Donadon","doi":"10.1159/000548423","DOIUrl":"10.1159/000548423","url":null,"abstract":"<p><strong>Introduction: </strong>While the resection of colorectal liver metastases is a well-established procedure, with survival rates superior to chemotherapy alone, controversial data still exist on liver resection for non-colorectal liver metastases (NCRLM). These patients comprise a diverse and heterogeneous group usually excluded from surgery. To date, only few retrospective reports are available on the surgical treatment of NCRLM. The NONCOLMET study aimed to build a comprehensive registry of patients undergoing liver resection for NCRLM, providing robust retrospective and prospective data to describe clinical practices, outcomes, and identify prognostic factors.</p><p><strong>Methods: </strong>The study consists of two phases: (1) retrospective collection of data from patients treated between 2010 and 2024 and (2) prospective enrolment from 2025. Patients aged ≥18 years with histologically confirmed NCRLM undergoing liver resection will be included. Data will be recorded via a standardized electronic case report form on the RedCap platform. The following endpoints will be evaluated: oncological outcomes including overall survival, disease-free survival, and disease relapse; post-operative mortality at 30 and 90 days with causes of death; post-procedural complications; predictor variables of short- and long-term outcomes. These outcomes will be used to elaborate a risk score model.</p><p><strong>Conclusions: </strong>NONCOLMET will offer crucial insights into the surgical management of NCRLM, helping refine patient selection criteria and informing future clinical guidelines.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"285-289"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145129923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes of Zenker's Diverticula Treatment: Invasive Procedures Ensure Sustained Quality of Life despite Higher Short-Term Morbidity. Zenker憩室治疗的长期结果:尽管短期发病率较高,但侵入性手术可确保持续的生活质量。
IF 1.2 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 Epub Date: 2025-06-06 DOI: 10.1159/000546619
Ulrich Nitsche, Marie Seitz, Helmut Friess, Hubertus Feussner, Norbert Hüser, Alissa Jell

Introduction: There is a lack of sufficient evidence-based data to support personalized treatment decisions for Zenker's diverticulum. This study evaluates not only short-term outcomes of different treatment approaches but also identifies prognostic factors for long-term recurrence-free survival and quality of life.

Methods: We retrospectively analyzed all patients diagnosed with Zenker's diverticulum at our center between 2001 and 2021. Long-term follow-up data, including validated quality-of-life scores (EAT-10 and GIQLI), were evaluated.

Results: Overall, 97 patients underwent open surgery (OS), 37 received endoscopic surgery (ES), and 17 patients were treated conservatively. Treatment-related morbidity was 25% for OS, 5% for ES, and nil for conservative management (p = 0.004). After a median follow-up of 107 months, patients treated with OS or ES experienced less dysphagia (p < 0.001) and regurgitation (p < 0.001) compared to initial presentation. ES patients had a more favorable quality-of-life score than those treated conservatively (GIQLI: 125 vs. 106; p = 0.010 but not EAT-10: 2 vs. 6; p = 0.207). Recurrence rates were 28% for OS, 62% for ES, and 65% for conservative treatment (p < 0.001). OS was identified as an independent prognostic factor for improved recurrence-free survival.

Conclusion: Despite higher short-term morbidity, OS was associated with the best recurrence-free survival. Long-term symptoms and quality-of-life outcomes were favorable and comparable between OS and ES.

目前缺乏足够的循证数据来支持Zenker憩室的个性化治疗决策。这项研究不仅评估了不同治疗方法的短期结果,而且还确定了长期无复发生存和生活质量的预后因素。方法回顾性分析2001年至2021年在本中心诊断为Zenker憩室的所有患者。评估长期随访数据,包括经验证的生活质量评分(EAT-10和GIQLI)。结果97例患者行开放手术(OS), 37例行内镜手术(ES), 17例保守治疗。治疗相关的发病率,OS为25%,ES为5%,保守治疗为零(p=0.004)。中位随访107个月后,接受OS或ES治疗的患者出现较少的吞咽困难(p
{"title":"Long-Term Outcomes of Zenker's Diverticula Treatment: Invasive Procedures Ensure Sustained Quality of Life despite Higher Short-Term Morbidity.","authors":"Ulrich Nitsche, Marie Seitz, Helmut Friess, Hubertus Feussner, Norbert Hüser, Alissa Jell","doi":"10.1159/000546619","DOIUrl":"10.1159/000546619","url":null,"abstract":"<p><strong>Introduction: </strong>There is a lack of sufficient evidence-based data to support personalized treatment decisions for Zenker's diverticulum. This study evaluates not only short-term outcomes of different treatment approaches but also identifies prognostic factors for long-term recurrence-free survival and quality of life.</p><p><strong>Methods: </strong>We retrospectively analyzed all patients diagnosed with Zenker's diverticulum at our center between 2001 and 2021. Long-term follow-up data, including validated quality-of-life scores (EAT-10 and GIQLI), were evaluated.</p><p><strong>Results: </strong>Overall, 97 patients underwent open surgery (OS), 37 received endoscopic surgery (ES), and 17 patients were treated conservatively. Treatment-related morbidity was 25% for OS, 5% for ES, and nil for conservative management (p = 0.004). After a median follow-up of 107 months, patients treated with OS or ES experienced less dysphagia (p < 0.001) and regurgitation (p < 0.001) compared to initial presentation. ES patients had a more favorable quality-of-life score than those treated conservatively (GIQLI: 125 vs. 106; p = 0.010 but not EAT-10: 2 vs. 6; p = 0.207). Recurrence rates were 28% for OS, 62% for ES, and 65% for conservative treatment (p < 0.001). OS was identified as an independent prognostic factor for improved recurrence-free survival.</p><p><strong>Conclusion: </strong>Despite higher short-term morbidity, OS was associated with the best recurrence-free survival. Long-term symptoms and quality-of-life outcomes were favorable and comparable between OS and ES.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"174-184"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1